Comment regarding benefit in phase 1 oncology trials

Affiliations

¹ Division of Medical Oncology, GI Oncology, Molecular Therapeutics Program, Duke South Clinics, Duke University Medical Center, Durham, NC, USA. michael.morse@duke.edu

Comment

Michael Morse. Clin Trials. 2008.

. 2008;5(6):626; discussion 630.

doi: 10.1177/1740774508098682.

¹ Division of Medical Oncology, GI Oncology, Molecular Therapeutics Program, Duke South Clinics, Duke University Medical Center, Durham, NC, USA. michael.morse@duke.edu

No abstract available

Comment on

Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option?
Miller FG, Joffe S. Miller FG, et al. Clin Trials. 2008;5(6):617-23. doi: 10.1177/1740774508097576. Clin Trials. 2008. PMID: 19029210